Clinical Trials Directory

Trials / Unknown

UnknownNCT04648592

Salt Intake, Microbiota, Immune Response and Endothelial Function in Hypertension

Impact of Salt Intake on Gut Microbiota, Th17 Immune Response and Endothelial Function in Hypertensive Patients

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
25 (estimated)
Sponsor
Hospital Clínico Universitario de Valladolid · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Hypertension is a significant cardiovascular risk factor which affects 45% of the adult population. Salt intake is essential in the development and progression of hypertension. A reduction in salt intake is associated with a reduction in blood pressure and a 25% lower risk of suffering a cardiovascular event. The mechanisms involved in the association between salt intake and blood pressure are a topic of discussion. Increased salt intake can modify cardiovascular function, inducing endothelial dysfunction, modyfing the activity of the immune system and increasing inflammation or oxidative stress. In recent years, dietary salt intake has been linked to intestinal depletion of certain genera of bacteria such as Lactobacillus. Tryptophan metabolites formed by these bacteria have been shown to modulate the activity of pro-inflammatory cells such as Th17/CD4+, interleukin 17a producing cells. Studies in animal models have demonstrated that interleukin 17a is able to raise blood pressure by hindering endothelium-dependent vasodilation mechanisms. It is also able to cause sodium and water retention, increase albuminuria, induce renal microvascular injury and vasoconstriction and promote vascular stiffening, cardiac hypertrophy and fibrosis. The main objective of this trial is to describe the relationship between salt intake, gut commensal microbiota, Th17 activity, endothelial dysfunction and blood pressure evolution in a sample of patients with essential hypertension.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTLow salt diet plus sodium chloride supplementsPatients will receive a low salt diet plus salt supplements.
DIETARY_SUPPLEMENTLow salt diet plus placeboPatients will receive a low salt diet plus placebo.

Timeline

Start date
2020-12-01
Primary completion
2021-12-01
Completion
2022-04-30
First posted
2020-12-01
Last updated
2021-02-12

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04648592. Inclusion in this directory is not an endorsement.